Topics

University of Cincinnati finds new option for liver transplant patients

19:00 EST 7 Nov 2019 | AAAS

(University of Cincinnati) Budesonide, a drug commonly used to treat Crohn's Disease, may offer fewer side effects and work at least as well as prednisone as an anti-organ rejection medication in liver transplant patients.

Original Article: University of Cincinnati finds new option for liver transplant patients

NEXT ARTICLE

More From BioPortfolio on "University of Cincinnati finds new option for liver transplant patients"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...